Long term control stereotactic body radiotherapy (SBRT) for oligometastatic colorectal cancer: a single center study | Zendy

Mireia Gil-Raga | Zendy; Marina Meri-Abad | Zendy; M.J. Safont Aguilera | Zendy; Ana Hernández Machancoses | Zendy; Miriam Lobo | Zendy; Sílvia Calabuig-Fariñas | Zendy; J. López Torrecilla | Zendy; Alejandro HerrerosPomares | Zendy; Carlos Camps Herrero | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long term control stereotactic body radiotherapy (SBRT) for oligometastatic colorectal cancer: a single center study

Author(s) -

Mireia Gil-Raga,

Marina Meri-Abad,

M.J. Safont Aguilera,

Ana Hernández Machancoses,

Miriam Lobo,

Sílvia Calabuig-Fariñas,

J. López Torrecilla,

Alejandro HerrerosPomares,

Carlos Camps Herrero

Publication year - 2020

Publication title -

chinese clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.733

H-Index - 22

eISSN - 2304-3873

pISSN - 2304-3865

DOI - 10.21037/cco.2020.01.10

Subject(s) - medicine , radiosurgery , colorectal cancer , univariate analysis , hazard ratio , cyberknife , proportional hazards model , stage (stratigraphy) , oncology , multivariate analysis , single center , radiation therapy , cancer , radiology , confidence interval , paleontology , biology

SBRT for oligometastatic disease is an effective option for patients with advanced CRC, with encorauging survival outcomes. However, a definitive validation in large randomized studies is required.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research